References
- BandyopadhyayAFineRLDementoSBockenstedtLKFahmyTMThe impact of nanoparticle ligand density on dendritic-cell targeted vaccinesBiomaterials201132113094310521262534
- ReuterAPanozzaSEMacriCCriteria for dendritic cell receptor selection for efficient antibody-targeted vaccinationJ Immunol201519462696270525653426
- ButlerMMorelASJordanWJAltered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturationImmunology2007120336237117163964
- PlatzerBStoutMFiebigerEAntigen cross-presentation of immune complexesFront Immunol2014514024744762
- BarbutoSIdoyagaJVila-PerelloMInduction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cellsNat Chem Biol20139425025623416331
- CooperDLHarirforooshSDesign and optimization of PLGA-based diclofenac loaded nanoparticlesPloS One201491e8732624489896
- DanhierFAnsorenaESilvaJMCocoRLe BretonAPreatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
- LewisJSZaveriTDCrooksCP2ndKeselowskyBGMicroparticle surface modifications targeting dendritic cells for non-activating applicationsBiomaterials201233297221723222796161
- HaddadiAHamdySGhotbiZSamuelJLavasanifarAImmuno-adjuvant activity of the nanoparticles’ surface modified with mannanNanotechnology2014253535510125119543
- SahHThomaLADesuHRSahEWoodGCConcepts and practices used to develop functional PLGA-based nanoparticulate systemsInt J Nanomedicine2013874776523459088
- GhotbiZHaddadiAHamdySHungRWSamuelJLavasanifarAActive targeting of dendritic cells with mannan-decorated PLGA nanoparticlesJ Drug Target201119428129220590403
- KeumCGNohYWBaekJSPractical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acidInt J Nanomedicine201162225223422114486
- ThamakeSIRautSLRanjanAPGryczynskiZVishwanathaJKSurface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapyNanotechnology201122303510121149963
- KocbekPObermajerNCegnarMKosJKristlJTargeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJ Control Release20071201–2182617509712
- ZouWLiuCChenZZhangNStudies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancerInt J Pharm20093701–218719519073241
- MukherjeeBSantraKPattnaikGGhoshSPreparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymersInt J Nanomedicine20083448749619337417
- Al-NemrawiNKDaveRHFormulation and characterization of acetaminophen nanoparticles in orally disintegrating filmsDrug Deliv201511025013958
- KaurRChitandaJMMichelDLysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studiesInt J Nanomedicine201273851386622904623
- ValenciaPMHanewich-HollatzMHGaoWEffects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticlesBiomaterials201132266226623321658757
- LiFSunJZhuHWenXLinCShiDPreparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicinColloids Surf B Biointerfaces2011881586221764271
- DillenKVandervoortJVan den MooterGVerheydenLLudwigAFactorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticlesInt J Pharm20042751–217118715081148
- TsaiYMChienCFLinLCTsaiTHCurcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetrationInt J Pharm2011416133133821729743
- MundargiRCBabuVRRangaswamyVPatelPAminabhaviTMNano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivativesJ Control Release2008125319320918083265
- CoppJAFangRHLukBTClearance of pathological antibodies using biomimetic nanoparticlesProc Natl Acad Sci U S A201411137134811348625197051
- SperlingRAParakWJSurface modification, functionalization and bioconjugation of colloidal inorganic nanoparticlesPhilos Trans A Math Phys Eng Sci201036819151333138320156828
- HermansKVan den PlasDEveraertAWeyenbergWLudwigAFull factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticlesEur J Pharm Biopharm2012821273522634236
- FontePSoaresSCostaAEffect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-dryingBiomatter20122432933923507897
- IkedaJSunYLAnKNAmadioPCZhaoCApplication of carbodiimide derivatized synovial fluid to enhance extrasynovial tendon gliding abilityJ Hand Surg Am201136345646321371626
- ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
- SampathMLakraRKorrapatiPSengottuvelanBCurcumin loaded poly(lactic-co-glycolic) acid nanofiber for the treatment of carcinomaColloids Surf B Biointerfaces201411712813424646452
- KountzSLThe effect of bioscience and technological momentum on the surgical treatment of chronic illnessSurgery19757767357401145439
- BarthAInfrared spectroscopy of proteinsBiochim Biophys Acta2007176791073110117692815
- GlassfordSEByrneBKazarianSGRecent applications of ATR FTIR spectroscopy and imaging to proteinsBiochim Biophys Acta20131834122849285823928299
- Cohen-SelaEChornyMKoroukhovNDanenbergHDGolombGA new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticlesJ Control Release20091332909518848962
- ChoiHSLiuWMisraPRenal clearance of quantum dotsNat Biotechnol200725101165117017891134
- KettigerHSchipanskiAWickPHuwylerJEngineered nanomaterial uptake and tissue distribution: from cell to organismInt J Nanomedicine201383255326924023514
- HamdySHaddadiAShayeganpourASamuelJLavasanifarAActivation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticlesPharm Res20112892288230121560020
- GutierroIHernandezRMIgartuaMGasconARPedrazJLSize dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheresVaccine2002211–2677712443664
- SoppimathKSAminabhaviTMEthyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer typeJ Microencapsul200219328129212022494
- SahanaDKMittalGBhardwajVKumarMNPLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drugJ Pharm Sci20089741530154217722098
- JoseSSowmyaSCinuTAAleykuttyNAThomasSSoutoEBSurface modified PLGA nanoparticles for brain targeting of Bacoside-AEur J Pharm Sci201463293525010261
- YonchevaKVandervoortJLudwigAInfluence of process parameters of high-pressure emulsification method on the properties of pilocarpine-loaded nanoparticlesJ Microencapsul200320444945812851045
- VandervoortJLudwigABiocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design studyInt J Pharm20022381–2779211996812
- WangHJiaYHuWJiangHZhangJZhangLEffect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcuminPharm Dev Technol201318369470022676257
- MobarakDHSalahSElkheshenSAFormulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variablesPharm Dev Technol201419789190024032531
- MakadiaHKSiegelSJPoly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers (Basel)2011331377139722577513
- SanadRAAbdel MalakNSEl-BayoomyTSBadawiAAPreparation and characterization of oxybenzone-loaded solid lipid nanoparticles (SLNs) with enhanced safety and sunscreening efficacy: SPF and UVA-PFDrug Discov Ther20104647248322491313
- VandervoortJYonchevaKLudwigAInfluence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticlesChem Pharm Bull (Tokyo)200452111273127915516745
- Nabi-MeibodiMVatanaraANajafabadiARThe effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation methodColloids Surf B Biointerfaces201311240841424036624
- Gomez-GaeteCBustosGLGodoyRRSuccessful factorial design for the optimization of methylprednisolone encapsulation in biodegradable nanoparticlesDrug Dev Ind Pharm201339231032023323873
- PremalethaKLicyCDJoseSSaraladeviAShirwaikarAShirwaikarAFormulation, characterization and optimization of hepatitis B surface antigen (HBsAg)-loaded chitosan microspheres for oral deliveryPharm Dev Technol201217225125821108582
- Awotwe-OtooDZidanASRahmanZHabibMJEvaluation of anticancer drug-loaded nanoparticle characteristics by nondestructive methodologiesAAPS PharmSciTech201213261162222535519
- LiXXuYChenGWeiPPingQPLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studiesDrug Dev Ind Pharm200834110711518214762
- WestesenKNovel lipid-based colloidal dispersions as potential drug administration systems expectations and realityColloid Polym Sci20002787608618
- Pinto ReisCNeufeldRJRibeiroAJVeigaFNanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticlesNanomedicine20062182117292111
- RizkallaNRangeCLacasseFXHildgenPEffect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion methodJ Microencapsul2006231395716830976
- Janz FdeLDebes AdeACavaglieri RdeCEvaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservationJ Biomed Biotechnol2012201264935322665987
- ZhangXGuanJNiRLiLCMaoSPreparation and solidification of redispersible nanosuspensionsJ Pharm Sci201410372166217624840928
- MuraSHillaireauHNicolasJInfluence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cellsInt J Nanomedicine201162591260522114491
- AbdelwahedWDegobertGStainmesseSFessiHFreeze-drying of nanoparticles: formulation, process and storage considerationsAdv Drug Deliv Rev200658151688171317118485
- JeongYIShimYHKimCLimGTChoiKCYoonCEffect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide)J Microencapsul200522659360116401576
- LamXMDuenasETDaughertyALLevinNClelandJLSustained release of recombinant human insulin-like growth factor-I for treatment of diabetesJ Control Release2000672–328129210825561